Albuminuria: is it time to screen the general population?
Related Experiment Video
Updated: May 30, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Deidra C Crews1, L Ebony Boulware, Ron T Gansevoort
1Department of Medicine, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD, USA.
Abstract:
Albuminuria has been associated with increased risk of multiple adverse outcomes, including ESRD, acute kidney injury, cardiovascular disease, and death. Some clinicians advocate for population-based screening of this condition, as a means of identifying individuals at high risk for morbidity and mortality. Several factors influence the potential implementation of screening for albuminuria in the general population, including the type of test used, the threshold for albuminuria, the validity and prognostic value of testing, frequency of follow-up testing, and associated costs of screening. This review discusses the available literature addressing these issues, and suggests an approach to screening patients for albuminuria.
Related Concept Videos
Diabetic Nephropathy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Nephrotic Syndrome I : Introduction
Nursing Assessment of the Genitourinary System I: Health History
